About The Conference
This conference brings together leading experts and healthcare professionals to explore the latest advances in the diagnosis, treatment, and multidisciplinary management of immune-mediated inflammatory diseases (IMIDs). With a focus on clinical practice, pharmacological updates, genetic insights, and innovative imaging techniques, the sessions are designed to enhance participant knowledge across dermatology, rheumatology, gastroenterology, hepatology, and beyond. Through a series of targeted learning objectives, attendees will gain practical skills in patient monitoring, differential diagnosis, and integrated care planning for complex IMID cases.
Conference Objectives
- Identify three common dermatologic signs of IBD and relate them to underlying inflammatory mechanisms
- Differentiate between two biologic treatments for IMIDs in terms of efficacy and safety
- Design a monitoring plan to detect adverse effects of biologic therapies across organ systems
- Outline how genetic and epigenetic factors influence IMID progression with at least two examples
- Describe two interdisciplinary strategies for managing uveitis in IMID patients
- Formulate a management approach for autoimmune hepatitis coexisting with primary sclerosing cholangitis
